NURS 684 FINAL EXAM VERSION 3 WEST
COAST UNIVERSITY EXAM| COMPLETE WITH
ANSWERS
T/F? gBone gdensity gis grecommended gin gall gwomen g2 gyears gpost-menopause. g-
gAnswer gFALSE
The gNational gOsteoporosis gFoundation g(NOF) gand gNorth gAmerican gMenopause
gSociety grecommend gthat gBMD g(bone gmineral gdensity) gbe gmeasured gin g
- gall gwomen gage g65 gand golder, gregardless gof gclinical grisk gfactors. g
- gpostmenopausal gwomen gwith gmedical gcauses gof gbone gloss gregardless gof gage
- gpostmenopausal gwomen gage g50 gand gover gwith gadditional grisk gfactors
- gpostmenopausal gwomen gwith ga glow-trauma gor gfragility gfracture
***remember g65+ gunless greason!
A g52-year-old gwoman gpresents gwith gamenorrhea gfor gone gyear gand gmoderate ghot
gflashes gfor g6 gmonths. gShe gis ginterested gin gbioidentical ghormone grelief gfor gher ghot
gflashes gand gwants gto gknow gif gthey gare gbetter gfor gher gthan gother ghormones.
gAppropriate ginfo gto gprovide gwould gbe, gwhat? g- gAnswer g17 gbeta-estradiol gis ga
gbioidentical gform gof gestrogen gavailable gin goral, gtransdermal, gand gvaginal
gformulations
Bioidentical ghormones gare gartificial ghormones gthat gare gused gto gtreat gpeople gwith
ghormonal gimbalances. gBioidentical ghormone greplacement gtherapy g(BHRT) gcan
ghelp grelieve gsymptoms gof ghormonal gimbalances gand gmenopause.
Which gof gthe gfollowing gstatements gconcerning gthe gestrogen gagonist/antagonist
graloxifine g(Evista) gis gcorrect? g- gAnswer gIt gis gapproved gfor gthe gprevention gand
gtreatment gof gosteoporosis.
Raloxifene gis gin ga gclass gof gmedications gcalled gselective gestrogen greceptor
gmodulators g(SERMs). gRaloxifene gprevents gand gtreats gosteoporosis gby gmimicking
gthe geffects gof gestrogen g(a gfemale ghormone gproduced gby gthe gbody) gto gincrease
gthe gdensity g(thickness) gof gbone. gEstrogen-mediated ginhibition gof gbone gresorption
gis ga gkey gplayer gin gnormal gbone gremodeling.
T/F? gData gsupports gthe guse gof gtopically gapplied gprogesterone gcreams gfor
gendometrial gprotection gin gmenopausal gwomen gtaking gestrogen. g- gAnswer gFALSE
The gstatement gis gfalse; gcurrent gdata gdoes gnot gsupport gthe guse gof gtopically
gapplied gprogesterone gcreams gas gthe gsole gmethod gfor gendometrial gprotection gin
gmenopausal gwomen gtaking gestrogen, gas gthe gabsorption gthrough gthe gskin gis
glimited gand gdoes gnot greach gsufficient gblood glevels gto gadequately gprotect gthe
gendometrium.
, It gis ggood gto gknow gthat gProgesterone gplays ga gcrucial grole gin gendometrial
gprotection gby gcounteracting gthe gproliferative geffects gof gestrogen, gessentially
gpreventing gthe guterine glining gfrom ggrowing gtoo gthick gand greducing gthe grisk gof
gendometrial ghyperplasia gand gcancer, gespecially gwhen gadministered galongside
gestrogen gtherapy gin gpostmenopausal gwomen gwith gan gintact guterus; gthis gmeans
gthat gadequate gprogesterone glevels gare gnecessary gto gmaintain ga ghealthy
gendometrium.
What gwould gNOT gbe gan gexpected gfinding gin ga gpelvic gexamination gof ga g70-year-
old gwoman? g- gAnswer gOvaries geasily gpalpable
A gmenopausal gwoman gexperiencing gdiscomfort gwith gsexual gintercourse grelated gto
gvaginal gdryness gwants gto gknow gwhether gshe gshould guse ga gvaginal glubricant gor ga
gvaginal gmoisturizer. gWhat gwould gNOT gbe ga gtrue gstatement?
a. gLubricants gare gintended gto greduce gfriction gr/t gsex
b. gLubricants gcan gtake gseveral gweeks gof guse gbefore gbecoming geffective
c. gMoisturizers gprovide glong-term grelief gof gvaginal gdryness gthan glubricants g
d. gMoisturizers gare gtypically gapplied gseveral gtimes gweekly g- gAnswer gB. gis gFALSE,
glubricants gare geffective gimmediately
Lubricants: gUsed gduring gsexual gactivity gto greduce gdiscomfort gand gprevent girritation.
gLubricants gcan gbe gwater-based, gnatural, gor gsynthetic goil-based. gWater-based
glubricants gare gbest gfor guse gwith gsilicone gsex gtoys, gwhile gnatural glubricants gare
gbest gfor gpeople gwith gskin gallergies. gOil-based glubricants gcan gdamage glatex
gcondoms.
Moisturizer: gUsed gregularly gto gmaintain gthe gskin's ghydration glevels gand gprevent
gdryness. gVaginal gmoisturizers gare gspecifically gformulated gfor gthe gdelicate gvaginal
gtissue gand gcan ghelp grelieve gdiscomfort gfrom gvaginal gdryness. gThey gcan gbe
gapplied gat gleast gtwo ghours gbefore gsex.
T/F? gData gsupports gthe guse gof ghormonal gtherapy gfor gprevention gof gcognitive
gdecline gif gstarted gsoon gafter gmenopause. g- gAnswer gFALSE
While gsome gstudies gindicate gthat gstarting ghormone gtherapy gearly gpost-menopause
gmay ghave ga gpositive gimpact gon gcognitive gfunction, gthe gresearch gis gnot gdefinitive
gand gother gstudies ghave gshown gno gsignificant gbenefit gor geven gincreased grisk gof
gdementia gin golder gpostmenopausal gwomen gtaking ghormone gtherapy.
An gadvantage gof gthe gtransdermal gpatch gover goral gdelivery gof gestrogen gfor gwomen
gexperiencing gmenopausal gsymptoms gis gthat gthe gtransdermal gdelivery
gmethod_____________________. g- gAnswer gHas gless gadverse geffects gon
gcoagulation gfactors! g
- gavoids gfirst-pass gmedication, gso git gcan gbe ggiven gin glower gdoses g
COAST UNIVERSITY EXAM| COMPLETE WITH
ANSWERS
T/F? gBone gdensity gis grecommended gin gall gwomen g2 gyears gpost-menopause. g-
gAnswer gFALSE
The gNational gOsteoporosis gFoundation g(NOF) gand gNorth gAmerican gMenopause
gSociety grecommend gthat gBMD g(bone gmineral gdensity) gbe gmeasured gin g
- gall gwomen gage g65 gand golder, gregardless gof gclinical grisk gfactors. g
- gpostmenopausal gwomen gwith gmedical gcauses gof gbone gloss gregardless gof gage
- gpostmenopausal gwomen gage g50 gand gover gwith gadditional grisk gfactors
- gpostmenopausal gwomen gwith ga glow-trauma gor gfragility gfracture
***remember g65+ gunless greason!
A g52-year-old gwoman gpresents gwith gamenorrhea gfor gone gyear gand gmoderate ghot
gflashes gfor g6 gmonths. gShe gis ginterested gin gbioidentical ghormone grelief gfor gher ghot
gflashes gand gwants gto gknow gif gthey gare gbetter gfor gher gthan gother ghormones.
gAppropriate ginfo gto gprovide gwould gbe, gwhat? g- gAnswer g17 gbeta-estradiol gis ga
gbioidentical gform gof gestrogen gavailable gin goral, gtransdermal, gand gvaginal
gformulations
Bioidentical ghormones gare gartificial ghormones gthat gare gused gto gtreat gpeople gwith
ghormonal gimbalances. gBioidentical ghormone greplacement gtherapy g(BHRT) gcan
ghelp grelieve gsymptoms gof ghormonal gimbalances gand gmenopause.
Which gof gthe gfollowing gstatements gconcerning gthe gestrogen gagonist/antagonist
graloxifine g(Evista) gis gcorrect? g- gAnswer gIt gis gapproved gfor gthe gprevention gand
gtreatment gof gosteoporosis.
Raloxifene gis gin ga gclass gof gmedications gcalled gselective gestrogen greceptor
gmodulators g(SERMs). gRaloxifene gprevents gand gtreats gosteoporosis gby gmimicking
gthe geffects gof gestrogen g(a gfemale ghormone gproduced gby gthe gbody) gto gincrease
gthe gdensity g(thickness) gof gbone. gEstrogen-mediated ginhibition gof gbone gresorption
gis ga gkey gplayer gin gnormal gbone gremodeling.
T/F? gData gsupports gthe guse gof gtopically gapplied gprogesterone gcreams gfor
gendometrial gprotection gin gmenopausal gwomen gtaking gestrogen. g- gAnswer gFALSE
The gstatement gis gfalse; gcurrent gdata gdoes gnot gsupport gthe guse gof gtopically
gapplied gprogesterone gcreams gas gthe gsole gmethod gfor gendometrial gprotection gin
gmenopausal gwomen gtaking gestrogen, gas gthe gabsorption gthrough gthe gskin gis
glimited gand gdoes gnot greach gsufficient gblood glevels gto gadequately gprotect gthe
gendometrium.
, It gis ggood gto gknow gthat gProgesterone gplays ga gcrucial grole gin gendometrial
gprotection gby gcounteracting gthe gproliferative geffects gof gestrogen, gessentially
gpreventing gthe guterine glining gfrom ggrowing gtoo gthick gand greducing gthe grisk gof
gendometrial ghyperplasia gand gcancer, gespecially gwhen gadministered galongside
gestrogen gtherapy gin gpostmenopausal gwomen gwith gan gintact guterus; gthis gmeans
gthat gadequate gprogesterone glevels gare gnecessary gto gmaintain ga ghealthy
gendometrium.
What gwould gNOT gbe gan gexpected gfinding gin ga gpelvic gexamination gof ga g70-year-
old gwoman? g- gAnswer gOvaries geasily gpalpable
A gmenopausal gwoman gexperiencing gdiscomfort gwith gsexual gintercourse grelated gto
gvaginal gdryness gwants gto gknow gwhether gshe gshould guse ga gvaginal glubricant gor ga
gvaginal gmoisturizer. gWhat gwould gNOT gbe ga gtrue gstatement?
a. gLubricants gare gintended gto greduce gfriction gr/t gsex
b. gLubricants gcan gtake gseveral gweeks gof guse gbefore gbecoming geffective
c. gMoisturizers gprovide glong-term grelief gof gvaginal gdryness gthan glubricants g
d. gMoisturizers gare gtypically gapplied gseveral gtimes gweekly g- gAnswer gB. gis gFALSE,
glubricants gare geffective gimmediately
Lubricants: gUsed gduring gsexual gactivity gto greduce gdiscomfort gand gprevent girritation.
gLubricants gcan gbe gwater-based, gnatural, gor gsynthetic goil-based. gWater-based
glubricants gare gbest gfor guse gwith gsilicone gsex gtoys, gwhile gnatural glubricants gare
gbest gfor gpeople gwith gskin gallergies. gOil-based glubricants gcan gdamage glatex
gcondoms.
Moisturizer: gUsed gregularly gto gmaintain gthe gskin's ghydration glevels gand gprevent
gdryness. gVaginal gmoisturizers gare gspecifically gformulated gfor gthe gdelicate gvaginal
gtissue gand gcan ghelp grelieve gdiscomfort gfrom gvaginal gdryness. gThey gcan gbe
gapplied gat gleast gtwo ghours gbefore gsex.
T/F? gData gsupports gthe guse gof ghormonal gtherapy gfor gprevention gof gcognitive
gdecline gif gstarted gsoon gafter gmenopause. g- gAnswer gFALSE
While gsome gstudies gindicate gthat gstarting ghormone gtherapy gearly gpost-menopause
gmay ghave ga gpositive gimpact gon gcognitive gfunction, gthe gresearch gis gnot gdefinitive
gand gother gstudies ghave gshown gno gsignificant gbenefit gor geven gincreased grisk gof
gdementia gin golder gpostmenopausal gwomen gtaking ghormone gtherapy.
An gadvantage gof gthe gtransdermal gpatch gover goral gdelivery gof gestrogen gfor gwomen
gexperiencing gmenopausal gsymptoms gis gthat gthe gtransdermal gdelivery
gmethod_____________________. g- gAnswer gHas gless gadverse geffects gon
gcoagulation gfactors! g
- gavoids gfirst-pass gmedication, gso git gcan gbe ggiven gin glower gdoses g
